发明名称 |
Method for treating myocardial infarct |
摘要 |
The invention relates to a method for influencing the miR-92 expression in a cell, comprising the following steps: (a) providing a cell; and (b1) reducing the miR-92 expression in the cell in order to promote the vascularization or vessel repair by introducing an antisense molecule against miR-92 into the cell, or (b2) increasing the miR-92 expression in the cell for an inhibition of the tumor angiogenesis by introducing a construct into the cell, wherein said construct includes an expressible miR-92 sequence. Furthermore, the invention relates to a pharmaceutical composition, comprising an agent for reducing the miR-92 activity or expression in a cell in the form of an antisense molecule against miR-92, or an agent for increasing the miR-92 expression in a cell in the form of a construct for expressing miR-92. |
申请公布号 |
US8912158(B2) |
申请公布日期 |
2014.12.16 |
申请号 |
US201213569786 |
申请日期 |
2012.08.08 |
申请人 |
t2cure GmbH |
发明人 |
Dimmeler Stefanie;Zeiher Andreas M.;Bonauer Angelika;Urbich Carmen |
分类号 |
C12N15/11;C12N15/113;C07H21/04 |
主分类号 |
C12N15/11 |
代理机构 |
Saliwanchik, Lloyd & Eisenschenk |
代理人 |
Saliwanchik, Lloyd & Eisenschenk |
主权项 |
1. A method for treating myocardial infarct in a subject in need thereof, wherein the method comprises administering intravenously an antisense molecule against miR-92a to said subject, wherein said antisense molecule reduces miR-92a expression and comprises a sequence according to SEQ ID NO: 6 or 8, wherein each nucleotide in the sequence comprises a 2′-O-methyl modification, and said antisense molecule comprises a phosphorothioate modification and a cholesterol group. |
地址 |
Frankfurt am Main DE |